ViBA

In silico clinical trial to predict the efficacy of alendronate for preventing hip fractures.

Oliviero S, Savelli G, Viceconti M · Clinical biomechanics (Bristol, Avon) · 2025 · Article

10.1016/j.clinbiomech.2025.106689

Verified evidence

Retrospective comparison with external trial outcomes

679c393b-625d-5b0e-a250-9af0e7d0a28b
Clinical events and scales

Prediction source Version of record · PDF page(s) 4

Study 118bd1a0-80e9-50e3-a3a1-513a288bbbd2 · Prediction record (JSON)

Prediction fields

Endpoint
hip_fracture_4_year_incidence__count · PDF page(s) 4
Family
clinical_outcomes · PDF page(s) 4
Measured variable
hip_fracture_4_year_incidence · PDF page(s) 4
Measurement role
clinical_outcome · PDF page(s) 4
Metric
count · PDF page(s) 4
Population
synthetic_or_virtual_cohort · PDF page(s) 1, 4
Reference type
observed_clinical_reference · PDF page(s) 4
Reported time window
four years of follow-up for fracture counts in both simulated cohorts · PDF page(s) 4
Role
simulated_event_rate · PDF page(s) 4
Scenario
simulated_trial_and_published_cohort_comparison · PDF page(s) 4

Validation Direct comparison · Same source · Sample overlap · Partial support · Partially comparable · Not reported